Jiangxi Fushine Pharmaceutical Co Ltd
300497
Company Profile
Business description
Jiangxi Fushine Pharmaceutical Co Ltd is engaged in research and development, manufactures and sells APIs and pharmaceutical intermediates. It offers penicillin, carbapenem, and other products.
Contact
No.2 YULI Industrial Zone
Changjiang district
Jiangxi Province
Jingdezhen333000
CHNT: +86 7982699929
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
31 December 2025
Employees
1,963
Stocks News & Analysis
video
What does the RBA rate cut mean for investors?
Morningstar's Chief Investment Officer for Asia-Pacific and Director of Personal Finance share their thoughts on the recent RBA rate cut.
stocks
Insights from reporting season: So far, so good
We’ve upgraded our fair value estimate for 29 companies, or 40% of those that have reported thus far.
stocks
3 cheap ASX stocks owned by top rated funds
Our analysts think these companies are undervalued and their shares appear to have the stamp of approval from highly rated managers.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,570.90 | 30.80 | -0.36% |
| CAC 40 | 8,146.20 | 23.62 | 0.29% |
| DAX 40 | 22,259.11 | 55.54 | -0.25% |
| Dow JONES (US) | 43,831.13 | 345.52 | -0.78% |
| FTSE 100 | 8,658.34 | 4.63 | -0.05% |
| HKSE | 23,477.92 | 900.94 | 3.99% |
| NASDAQ | 19,852.84 | 109.52 | -0.55% |
| Nikkei 225 | 38,776.94 | 98.90 | 0.26% |
| NZX 50 Index | 12,752.58 | 127.78 | -0.99% |
| S&P 500 | 6,088.34 | 29.18 | -0.48% |
| S&P/ASX 200 | 8,296.20 | 26.60 | -0.32% |
| SSE Composite Index | 3,379.11 | 28.33 | 0.85% |